Abstract
Ultraviolet-C (UVC) disinfection has gained considerable attention as a continuous, real-time method to mitigate the transmission of airborne pathogens within aircraft cabins. Recent investigations have demonstrated its potential to inactivate viruses such as SARS-CoV-2, influenza, and other emerging infectious agents in situ, thereby reducing both immediate infection risks and broader public health burdens. This commentary evaluates how continuous UVC disinfection—applied in tandem with established preventive measures—may effectively curtail disease transmission, reassure passengers, and inform the future direction of in-flight health and safety standards.
Keywords
Introduction
A
Among these novel methods, continuous UVC disinfection has emerged as a promising “layered defense” measure, offering the potential to neutralize airborne pathogens while the aircraft is in operation.4,5 Observations from recent influenza seasons and the COVID-19 pandemic underscore the need for strategies that address constant pathogen reintroduction. 1 Although single-event surface disinfection helps, it does not resolve ongoing contamination from coughing or sneezing passengers. In a world where viral variants and new disease threats continue to emerge, UVC disinfection is increasingly viewed as a valuable adjunct to standard filtration and cleaning protocols.
A recently published risk versus benefit analysis provides details and references that help to quantify the benefits of using UVC light for air disinfection in aircraft versus the risk of overexposure to UVC for passengers and crew. 5 The analysis estimated that, due to the combined transmission of SARS-CoV-2 and influenza A aboard commercial aircraft in the United States over the 3-year period ending May 2023, there were approximately 10,000 annual deaths, declining to 3,000 per year going forward, with an estimated annual economic burden of $200 billion each year. Up to 80% of the deaths and economic burden might be saved by supplementing the typical 30 air changes per hour of the aircraft ventilation system with a presently available 120 air changes per hour equivalent, using a UVC disinfection system. The risks due to accidental overexposure to UVC are orders of magnitude lower than the benefits. The 0.00003% risk of acute (one time) overexposure for any given passenger may (or may not) result in a 1- to 2-day skin or eye irritation, with no long-term effects or risks, compared to the 15,000 times greater risk, at 0.5%, of contracting COVID-19 or influenza A that persists for several days to weeks, and carries a risk of hospitalization or death. The estimated risk of nonmelanoma skin cancer is virtually nil. 5
Recent Evidence and Findings
Recent reviews and studies have provided key insights into the limitations of static or once-daily disinfection methods. 1 For instance, robotic systems that clean aircraft cabins in the absence of passengers are effective at neutralizing pathogens on surfaces prior to boarding, yet they cannot address newly introduced pathogens during flight.4-6 This limitation has prompted investigations into continuous UVC systems that operate throughout the flight.
In a 2024 review, UVC disinfection was described as an additional “slice” in a larger “Swiss cheese” model, wherein each layer (eg, masking, HEPA filtration, chemical disinfectants) has weaknesses that are compensated for by adding more layers. 4 A subsequent 2025 risk–benefit analysis estimated that continuous UVC systems might reduce in-flight transmission by as much as 80%, suggesting significant potential for both public health and economic benefits. 5 These findings emphasize the complementary nature of UVC disinfection in a multifaceted approach to inflight infection control and underscore its relevance in preventing the spread of emerging diseases. 4
Mechanisms of UVC Disinfection
UVC radiation inactivates microorganisms primarily by damaging their nucleic acids, thus impairing replication.7,8 While the traditional wavelength of 254 nm remains effective, there is growing interest in far-UVC (∼200-230 nm) and UV-LED technologies because these may offer lower risk to human skin and eyes during extended exposures.9-11 Importantly, far-UVC does not penetrate the outermost layers of the skin or eyes as deeply as longer UVC wavelengths, thereby reducing the risk of DNA damage in human tissues at prescribed exposure levels. These properties have prompted interest in integrating UVC systems into cabin lighting and ventilation infrastructure to enable continuous disinfection of air with minimal structural modification.1-4 However, a notable disadvantage of 222 nm UVC is its ability to generate ozone (O3) indoors—studies have shown that even at low concentrations, ozone can form and may accumulate depending on lamp power and ventilation conditions 12 and less efficacy than 260 nm to 265 nm against pathogens. 7
Such continuous exposure is the key strength of UVC in this setting: if viral or bacterial particles are released during flight, an active UVC system can neutralize them in real time. 4 This capability is especially helpful for curbing emerging respiratory pathogens like novel influenza strains or coronaviruses that appear unexpectedly and spread rapidly.2-5
Practical Applications
During the COVID-19 pandemic, multiple airlines evaluated UVC cabin disinfection approaches used during aircraft turnarounds, including portable UVC systems and autonomous UVC disinfection robots operated when cabins were unoccupied.22-25 By contrast, continuous UVC emitters optimally mounted on cabin ceilings potentially offer real-time pathogen reduction.4,5 Such systems can significantly bolster the cabin’s equivalent air-exchange rates, particularly while an aircraft is on the ground and ventilation may be reduced. 5
Safety and Regulatory Considerations
UVC safety remains an essential concern. Excessive exposure, above recommended exposure limits, can harm eyes or skin, raising questions about whether continuous inflight operation is advisable.4,9 However, recent research indicates that properly designed UVC or LED-based systems can maintain passenger and crew exposure well below established safety thresholds.10,13 Regulatory bodies, including the US Federal Aviation Administration (FAA), have begun considering UVC as a potential viable supplement to existing aircraft sanitation measures, although currently only support unoccupied UVC airborne use with a barrier between the system and passengers. 26 Airlines interested in implementing such systems must navigate certification pathways (eg, technical standard orders, functional hazard assessments) and ensure that crew members are adequately trained.15-17 Maintenance considerations and integration with existing cabin systems also factor into the rollout of UVC devices. Nonetheless, growing evidence shows that well-regulated, appropriately monitored UVC systems can be safe for continuous operation in an aircraft environment.2,4,11
Economic and Public Health Implications
Although introducing UVC equipment entails upfront costs, the potential public health and economic benefits may justify the investment. The Allen 2025 analysis estimated that in-flight transmissions of respiratory viruses can impose economic losses of up to $200 billion annually in the United States alone during peak pandemic periods, owing to healthcare expenses, productivity disruptions, and decreased consumer confidence. 5 Even under mild conditions, these factors represent significant financial burdens for airlines and the broader economy.
By reducing airborne viral transmission—including emerging diseases—UVC installations can help airlines minimize operational disruptions and build passenger trust.4,5 While the primary risks associated with UVC disinfection are to the workers working in the environment, particularly through direct and repeated exposure to UVC light—these risks can be mitigated through appropriate safety protocols, training, manufacturing and engineering controls. In alignment with the James Reason Swiss cheese model of risk mitigation, UVC disinfection should be viewed not as a standalone solution, but rather as a valuable addition to established practices such as frequent handwashing, masking (when indicated), routine surface disinfection, and high-efficiency ventilation systems.4,18
Challenges and Future Directions
Retrofitting existing aircraft cabins with UVC systems is not without complications. Different aircraft models have unique interior layouts—seats, bins, lighting, and HVAC ductwork—that must be considered. 1 Concerns persist around the long-term safety implications for flight attendants and frequent flyers exposed to UVC over many flight hours.13,26 More large-scale studies are needed to confirm UVC’s safety profile and effectiveness against a wide range of pathogens, including newly emerging strains.9,10,19 In addition to civilian aviation interest, this line of investigation has attracted institutional interest from US Department of Defense aerospace medicine research organizations (Director, Naval Aerospace Medical Research Laboratory, written communication, 2025).
Research trends emphasize the refinement of UVC technologies, which may offer effective microbial inactivation at wavelengths with minimal risk to humans.11,13,20 Additional areas of development include portable UVC devices and advanced sensors capable of real-time pathogen detection, enabling automated adjustments in UVC dosing 21 and safety features that will turn off, or reduce human vicinity exposures. As airlines refine these integrated systems, consistent staff training and adherence to safety protocols will be crucial to protect both crew and passengers.1,5,14
In addition to civilian aviation interest, professional aerospace medicine organizations have articulated formal policy support for the careful evaluation of continuous UVC disinfection within a layered risk-mitigation framework. In a resolution transmitted to the US Federal Air Surgeon, the Aerospace Medical Association (AsMA) emphasized that such technologies should be considered only when operated below established exposure limits and with appropriate engineering safeguards. The AsMA resolution specifically states: “The continuous use of UVC aboard aircraft, below exposure limits, and with appropriate engineering safeguards, can be an additional synergistic, safe, and effective risk-mitigation layer to reduce disease transmission and translocation.”
Conclusion
Once viewed as a niche sanitation approach, UVC disinfection has gained recognition as a potentially valuable adjunct within a layered strategy for mitigating infectious disease transmission in aircraft cabins. In contrast to intermittent surface cleaning, UVC offers the ability to continuously inactivate airborne pathogens when operated below established exposure limits and incorporated with appropriate engineering safeguards, features that align with the dynamic and densely occupied aircraft cabin environment. Modeling analyses suggest that, under appropriate assumptions and system designs, UVC systems may substantially reduce in-flight transmission, with possible downstream benefits for public health, passenger confidence, and airline economics.
While regulatory, operational, and certification challenges remain, continued advances in UVC and UVC LED technologies, together with accumulating safety data and growing professional consensus, support continued evaluation of UVC as a complementary risk-mitigation layer rather than a standalone solution. If ongoing research and operational experience continue to confirm its safety and effectiveness, continuous UVC disinfection may ultimately assume a role alongside established measures such as ventilation, filtration, and hygiene practices in future aircraft cabin health protection strategies.
Footnotes
Acknowledgments
This collaboration originated from a formal request by the Federal Aviation Administration for an expert review of current UVC disinfection science, specifically as it relates to mitigating disease transmission on aircraft. In response, we conducted comprehensive systematic literature reviews and provided an objective analysis of the efficacy and safety of UVC technology for in-flight pathogen reduction. The content of this commentary is intended solely as an unbiased scientific assessment of disinfection strategies, including the use of UVC. It does not constitute an endorsement of any specific products or services, including those developed by AeroClenz or other affiliated entities.
